share_log

HC Wainwright & Co. Reiterates Buy on Reneo Pharmaceuticals, Maintains $30 Price Target

HC Wainwright & Co. Reiterates Buy on Reneo Pharmaceuticals, Maintains $30 Price Target

HC Wainwright & Co.重申買入瑞諾製藥,維持30美元的目標股價
Benzinga ·  2023/10/12 06:26

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Reneo Pharmaceuticals (NASDAQ:RPHM) with a Buy and maintains $30 price target.

HC Wainwright&Co.分析師米切爾·卡普爾重申雷諾製藥(納斯達克:RPHM)買入,並維持30美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論